Steven A. Narod
Centre for Research on Women's Health
Women's College Hospital
University of Toronto
Ontario
Canada
Name/email consistency: high
- Method of cooking and risk of breast cancer in the Philippines. Kotsopoulos, J., Liede, A., De Matsuda, M.L., Sun, P., Narod, S.A. Cancer. Causes. Control (2006)
- Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. Metcalfe, K.A., Foulkes, W.D., Lynch, H.T., Ghadirian, P., Tung, N., Olivotto, I.A., Warner, E., Olopade, O., Eisen, A., Weber, B., McLennan, J., Sun, P., Narod, S.A. Hered. Cancer. Clin. Pract (2005)
- The prevention of hereditary breast and ovarian cancer: a personal view. Narod, S. Hered. Cancer. Clin. Pract (2004)
- Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer. Narod, S.A., Boyd, J. Curr. Opin. Obstet. Gynecol. (2002)
- What options for treatment of hereditary breast cancer?. Narod, S. Lancet (2002)
- Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Narod, S.A., Dubé, M.P., Klijn, J., Lubinski, J., Lynch, H.T., Ghadirian, P., Provencher, D., Heimdal, K., Moller, P., Robson, M., Offit, K., Isaacs, C., Weber, B., Friedman, E., Gershoni-Baruch, R., Rennert, G., Pasini, B., Wagner, T., Daly, M., Garber, J.E., Neuhausen, S.L., Ainsworth, P., Olsson, H., Evans, G., Osborne, M., Couch, F., Foulkes, W.D., Warner, E., Kim-Sing, C., Olopade, O., Tung, N., Saal, H.M., Weitzel, J., Merajver, S., Gauthier-Villars, M., Jernstrom, H., Sun, P., Brunet, J.S. J. Natl. Cancer Inst. (2002)
- Modifiers of risk of hereditary breast and ovarian cancer. Narod, S.A. Nat. Rev. Cancer (2002)
- Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. Narod, S.A., Sun, P., Ghadirian, P., Lynch, H., Isaacs, C., Garber, J., Weber, B., Karlan, B., Fishman, D., Rosen, B., Tung, N., Neuhausen, S.L. Lancet (2001)
- Hormonal prevention of hereditary breast cancer. Narod, S.A. Ann. N. Y. Acad. Sci. (2001)
- Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Narod, S.A., Brunet, J.S., Ghadirian, P., Robson, M., Heimdal, K., Neuhausen, S.L., Stoppa-Lyonnet, D., Lerman, C., Pasini, B., de los Rios, P., Weber, B., Lynch, H. Lancet (2000)
